C-MAC Video Laryngoscope and VS-CMAC Fiberoptic Stylet for Awake Endoscopic Intubation in Predicted Difficult Airways

August 25, 2020 updated by: Abele Donati, MD, Università Politecnica delle Marche

A Comparison Between C-MAC Video Laryngoscope an VS-CMAC Rigid Fiberoptic Stylet for Awake Endoscopic Intubation in Severe Predicted Difficult Airways: a Randomized Controlled Trial

An Anticipated difficult tracheal intubation is recommended to be managed performing the so called "Awake tracheal endoscopic intubation" (ATI) with the maintenance of patient's spontaneous breathing after an adequate sedation and topical anesthesia of upper airways, providing supplemental oxygen.

Initially only flexible bronchoscope was considered the device of choice (the gold standard) for ATI but in the last decade videolaryngoscopes with hyper-angulated blade have been demonstrated to be an efficacy technique.

Most recently, endoscopic rigid stylets such as Bonfils (Carl Storz™) and Sensacope (Acoutronic™) have been proposed as alternative techniques for ATI in the event of expected difficult tracheal intubation.

However, to date, no comparison studies have been carried out between these two kind of devices, alternative to flexible fiberscope, for ATI.

This is a clinical prospective randomized-controlled trial of non inferiority. The aim of this study is to compare the intubation success rate between two different devices (C-MAC Video Laryngoscope and VS-CMAC fiberoptic stylet) in patients with severe predicted difficult airways scheduled for elective surgery.

The primary endpoint is the comparison of success rate for the tracheal intubation, demonstrating the non inferiority of videostylet efficacy compared to the most consolidated technique based on videolaryngoscope.

Study Overview

Detailed Description

This is a clinical prospective randomized-controlled trial of non inferiority, set in the operating theatre of a terziary university hospital in Ancona (Ospedali Riuniti Ancona).

The aim of this study is to compare the intubation success rate, defined as correct positioning of the tracheal tube inside the trachea, between Videostylet (VS-Carl Storz™) and videolaryngoscope with hyperangulated blade (C-MAC - Carl Storz™) in patients with severe predicted difficult airways scheduled for elective surgery.

All patients enrolled in the study, examined in the pre-operative visit, will be asked for informed consent and will undergo the same anesthetic protocol consisting in upper airways topicalization with Lidocaine and in smooth/moderate sedation (targeted on Ramsay sedation scale ≦ 3) by i.v. administration of midazolam 0,03 mg/kg and Fentanyl 100 mcg.

On arrival in the operating room, nasal oxygen (5 L/min) and routine monitoring of vital signs will be applied to all patients.

Heart rate and blood pressure will be recorded at the beginning of the procedure and every 3 minutes until the intubation will be performed, while arterial oxygen saturation is continuously recorded.

Patients enrolled will be randomly divided into 2 groups regarding to the device used for ATI:

  1. Videolaryngoscope (C-MAC) with Hyperangulated blade (D-blade)
  2. Videostylet (VS) Endotracheal tube will be 6,5-7,0 mm for female and 7,5-8,0 mm for male.

The following parameters will be registered:

  • success rate of the procedure defined as correct positioning of the tracheal tube in the trachea confirmed both endoscopically and through the capnographic curve EtCO2
  • average time of intubation procedure expressed in sec.
  • operator's assessment of the subjective difficulty / handling of the device by means of a special analogue numerical scale
  • assessment of the patient's tolerance to the procedure by means of a special analogue numerical scale checked after patient's awakening from anesthesia at the end of the intervention.
  • occurrence of any complications or adverse event during the procedure (desaturation episodes, hemodynamic changes, oral-pharynx and larynx traumatism)

The primary endpoint is the comparison of success rate for the tracheal intubation in patients with anticipated difficult airways, demonstrating the non inferiority of videostylet efficacy compare to the most consolidated technique based on videolaryngoscope.

The Null Hypothesis will be the following: The rate of Awake tracheal intubation failure with the VS video stylet is > 10% compared to video-laryngoscope.

Considering an unsuccessful intubation rate with the two devices at 10%, a sample of 34 patients (17 per group) is necessary to demonstrate with a power of 90% and alpha error of 0.05 that the rate of intubation failure using the videosylet (study method) does not exceed 10% of the rate of failed intubations through the use of the video laryngoscope (reference method).

Statistical analysis:

Normally distributed data will be expressed as mean ± standard deviation and 95% confidence interval, while data with non-normal distribution will be expressed as median and interquartile range.

The differences between means will be studied by parametric tests (e.g. Student's t) if the data are normally distributed and by nonparametric tests (e.g. Wilcoxon) if the distribution is not normal. The Kolmogorov-Smirnov test will be used to evaluate the normality of continuous variables.

The characteristics of the patients in the two groups will be compared using the Fisher test or the Chi-square test for the nominal variables and the Student t test or the Mann - Whitney U test for the continuous variables.

For each test p < 0.05 will be considered significant. For the primary endpoint: The difference in awake tracheal intubation success rate in the two groups will be assessed using Fisher's exact test. The non-inferiority of the use of the videostylet (VS) compared to the standard method (videolaryngoscope with D-Blade blade) will be confirmed if the difference, for 95% confidence interval, is less than the margin of non- inferiority established "a priori" as 10% after analysis of the literature (Alhomary et al. Anaesthesia 2018; 73: 1151-61)9 and according to clinical judgment.

For the secondary endpoints of the study a purely analytical-descriptive evaluation will be carried out.

Study Type

Interventional

Enrollment (Anticipated)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Stefano Falcetta, MD
  • Phone Number: 00390715964603
  • Email: falmed@libero.it

Study Locations

      • Ancona, Italy, 60126
        • Recruiting
        • AOU Ospedali Riuniti Ancona - Università Politecnica delle Marche
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Schedule for elective surgery
  • Detection of one or more of the following anthropometric criteria predictive of difficult intubation at the preoperative visit:

    1. Limitation of Cervical spine movements (traumatic or surgical arthrodesis)
    2. Mallampati score = 4
    3. Thyromental distance < 6 cm
    4. Interincisor distance < 3 cm
    5. Suspected difficult ventilation via face mask
    6. Previous history of difficult or failed intubation

Exclusion Criteria:

  • age <18 years
  • refusal of the patient
  • urgent-emergency surgery
  • patient's respiratory failure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: C-MAC Video laryngoscope awake intubation
In this group, patients with severe predicted difficult airways scheduled for elective surgery receive awake endoscopic intubation using Videolaryngoscope (C-MAC) with Hyperangulated blade (D-blade) Spontaneous breathing will be preserved in both groups of patients enrolled and the same protocol of sedation plus upper airways topical anesthesia will be applied.
patients with severe predicted difficult airways scheduled for elective surgery randomized to this groups will receive awake endoscopic intubation using C-MAC Video Laryngoscope intubation.
Other Names:
  • videolaryngoscope with hyperangulated blade
EXPERIMENTAL: VS-CMAC Rigid Fiberoptic Stylet awake intubation

In this group, patients with severe predicted difficult airways scheduled for elective surgery receive awake endoscopic intubation using VS-CMAC Rigid Fiberoptic Stylet.

Spontaneous breathing will be preserved in both groups of patients enrolled and the same protocol of sedation plus upper airways topical anesthesia will be applied.

patients with severe predicted difficult airways scheduled for elective surgery randomized to this groups will receive awake endoscopic intubation using VS-CMAC Rigid Fiberoptic Stylet.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the success rate of the rigid fiberoptic stylet to perform tracheal intubation in patients with anticipated difficult airways
Time Frame: up to a maximum of 3 attempts and up to 3 minutes from device insertion for each attempt (max 9 minutes)

The primary endopoint is the comparison of success rate for the tracheal intubation in patients with anticipated difficult airways, demonstrating the non inferiority of videostylet efficacy compare to the most consolidated technique based on videolaryngoscope.

success rate of the procedure defined as correct positioning of the tracheal tube in the trachea confirmed both endoscopically and through the capnographic curve EtCO2

up to a maximum of 3 attempts and up to 3 minutes from device insertion for each attempt (max 9 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numbers of intubation attempts
Time Frame: up to a maximum of 3 attempts and up to 3 minutes from device insertion for each attempt (max 9 minutes)
number of attempt to intubation. intubation will be considered complete when the ETT (endotracheal tube) will be positioned correctly into the trachea
up to a maximum of 3 attempts and up to 3 minutes from device insertion for each attempt (max 9 minutes)
average time of intubation procedure expressed in seconds
Time Frame: up to 15 minutes
Time in minutes measured from device insertion into the patient's mouth until theETT will be positioned into the trachea
up to 15 minutes
Development of any complications
Time Frame: up to 12 hours measured from the insertion of the device
occurrence of any complications or adverse event during the procedure (desaturation episodes, hemodynamic changes, oral-pharynx and larynx traumatism)
up to 12 hours measured from the insertion of the device
The degree of patient's tolerability of the procedure (with a special Analogue Numerical Scale)
Time Frame: up to 12 hours from the beginning of the procedure (from starting of awake intubation to complete recovering from general anaesthesia)
assessment of the patient's tolerance to the procedure by means of the Visual Numerical Scale checked after patient's awakening from anesthesia at the end of the intervention. The Numerical Analogue Scales is a measurement instrument for tolerance-intensity. it consists of a numerical line from 1 to 5 with the endpoints defining extreme limits that are 5="not possible to tolerate at all" and 1="easily tolerable". the patient is asked to mark his tolerance-level on the line between the two endpoints
up to 12 hours from the beginning of the procedure (from starting of awake intubation to complete recovering from general anaesthesia)
The degree of subjective difficulty experienced by the operator
Time Frame: up to 15 minutes (from device insertion into the patient's mouth until the ETT will be positioned into the trachea)
operator's assessment of the subjective difficulty / handling of the device by means of a special analogue numerical scale from 1 to 5, where 1=no subjective difficulty and 5=maximal subjective difficulty
up to 15 minutes (from device insertion into the patient's mouth until the ETT will be positioned into the trachea)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 27, 2020

Primary Completion (ANTICIPATED)

December 31, 2020

Study Completion (ANTICIPATED)

December 31, 2020

Study Registration Dates

First Submitted

July 21, 2020

First Submitted That Met QC Criteria

August 25, 2020

First Posted (ACTUAL)

August 31, 2020

Study Record Updates

Last Update Posted (ACTUAL)

August 31, 2020

Last Update Submitted That Met QC Criteria

August 25, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Difficult Airway Intubation

Clinical Trials on C-MAC Video laryngoscope awake intubation

3
Subscribe